ArticleProceedings of the National Academy of Sciences of the United States of America2023

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers.

Yi Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.